97 results
Page 4 of 5
8-K
EX-99.1
lum4h15eqts6lx1bvd
13 Sep 21
InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare Cannabinoids
8:00am
424B3
m61bhd0y
22 Jul 21
Prospectus supplement
10:27am
8-K
EX-99.1
yobg4pzsp0kro63ev
2 Jul 21
InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement
4:27pm
8-K
EX-99.1
o0db8
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am
8-K
EX-99.1
trkttcsv1ekn7bp5 yz0
29 Jun 21
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
3:12pm
8-K
EX-99.1
p6f8 n5vi0im30qib
23 Jun 21
Regulation FD Disclosure
12:00am
8-K
EX-99.1
f0w8qt1qgq8
17 Jun 21
Regulation FD Disclosure
1:19pm
8-K
EX-99.1
hqxdtv94 wm
13 May 21
InMed Pharmaceuticals Reports Third Quarter Fiscal 2021 Financial Results
4:23pm
8-K
EX-99.1
81d6fis
28 Apr 21
Regulation FD Disclosure
1:31pm
8-K
EX-99.1
vr9aw4235viwa26dz35e
27 Apr 21
Regulation FD Disclosure
4:22pm
8-K
EX-99.2
y9hun8zkqowifk91zpnj
27 Apr 21
Regulation FD Disclosure
4:22pm
424B3
pmju8m072mcdfrusnrhn
16 Mar 21
Prospectus supplement
12:00am
8-K
EX-99.1
yy0a8 19s2z
16 Feb 21
InMed Announces Closing of US$4.5 Million Private Placement
6:12am
8-K
EX-99.1
pxacuij l8pmzaar8
12 Feb 21
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results
12:35pm
8-K
EX-99.1
f8kguc mato23z
5 Feb 21
InMed Announces US$4.5 Million Private Placement
5:28pm
8-K
EX-99.1
oyq0c2q
20 Jan 21
Regulation FD Disclosure
3:43pm
8-K
EX-99.1
2tupq
8 Jan 21
InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
10:53am
10-Q
ar93kapa rrwmijf
17 Dec 20
Quarterly report
12:00am